Comparison of mirtazapine and citalopram in the treatment of depression in patients with breast cancer

Phase 1

Recruiting

• Conditions: Major Depression, Breast Cancer, Mirtazapine, Citalopram.; Malignant neoplasm of breast, major depression; C50 , F32

• Registration Number: IRCT20220406054440N1
• Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 42

Inclusion Criteria

Females with breast cancer after radiotherapy surgery and undergoing chemotherapy or radiotherapy in stages 1 to 4 of disease progression
Age over 18 years and under 65 years
Middle school education level and higher
Existence of major depression criteria based on DSM-V criteria

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified